Amphivena Therapeutics

About:

Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops a platform of dual-function biologics.

Website: https://amphivena.com/

Top Investors: Qiming Venture Partners, Mérieux Equity Partners, +ND Capital, Aju IB Investment, MPM Capital

Description:

Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops a platform of dual-function biologics. Its Amphivena ReSTORE platform provides dual-action biologics that relieve immune suppression and activate T cell effector function in cancer patients. The platform design integrates elements of avidity, target selectivity, and enhanced safety within a single molecule. It is also can be engineered with additional solid tumor targeting modalities to add functionality such as directed tumor cell killing. It was founded in 2012 and is headquartered in South San Francisco, California.